Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of dutogliptin added to pioglitazone in type 2 diabetes mellitus
2009-012598-37Phase 3Terminated
- Sponsor
- Forest Research Institute
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Dutogliptin + pioglitazone with Placebo + pioglitazone (2 arms). Primary endpoint: HbA1c level. Started Sep 2009; status: terminated.
02
Drugs
dutogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-012598-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012598-37.